Global Exogenous Circular RNA Synthesis Service Market 2026 by Company, Regions, Type and Application, Forecast to 2032
According to our (Global Info Research) latest study, the global Exogenous Circular RNA Synthesis Service market size was valued at US$ 44.24 million in 2025 and is forecast to a readjusted size of US$ 213 million by 2032 with a CAGR of 24.7% during review period.
Exogenous circular RNA synthesis services refer to specialized technical services that produce artificial circular RNA outside living cells based on customer-provided or jointly optimized sequences. The workflow typically includes DNA template construction, in vitro transcription, precursor RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. The delivered RNA has already formed a covalently closed circular structure before being introduced into cells, tissues, or living organisms. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circRNA samples, preclinical drug substance, formulated samples, process-development packages, and GMP-compliant clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials. Downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutes, and hospital research centers. Pricing is generally determined by sequence length, delivery scale, circularization method, purity grade, analytical requirements, formulation needs, and quality-system requirements. Research-grade projects are usually priced by sequence and quantity, while clinical and industrial projects are priced through process-development and batch-manufacturing contracts. The industry's overall gross margin in 2025 is estimated at approximately 40%?60%.
The exogenous circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although customer demand is expanding from basic circRNA sample preparation to sequence optimization, circularization screening, impurity removal, analytical method development, and delivery formulation. Early suppliers mainly delivered microgram- to milligram-scale research samples, while several integrated service providers have developed larger-scale production, LNP formulation, and clinical-grade quality systems. Global supply is concentrated mainly in China and the United States. Chinese providers have developed broad capabilities in circularization processes, research services, and integrated CRDMO support, while U.S.-based providers generally benefit from international customer coverage, standardized service models, and established nucleic acid development infrastructure. The market remains characterized by a limited supplier base, highly customized projects, and revenues concentrated in the development stage.
Future competition will shift from basic circularization capability toward high purity, scarless products, long-sequence compatibility, low immunogenicity, and reproducible scale-up. Conventional PIE methods have a relatively established application base but may face challenges involving junction scars, sequence restrictions, and by-product control. Modified scarless PIE and ligase-based approaches offer greater sequence flexibility but impose additional requirements on terminal structure, splint design, enzyme cost, and downstream purification. As customer programs enter clinical development, residual linear RNA, double-stranded RNA, truncated transcripts, free intron fragments, and residual DNA will become increasingly important quality attributes. Suppliers with proprietary analytical methods and biological potency testing capabilities will gain a stronger competitive position.
Market growth is being driven by expanding development activity in circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo cell therapies, and gene-editing research. Compared with building internal in vitro transcription and circularization platforms, outsourcing gives developers access to validated templates, circularization elements, purification processes, and analytical systems, reducing development risk and shortening timelines to animal studies and regulatory submissions. As programs move from discovery to preclinical and clinical stages, additional testing for circularization efficiency, purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency expands the service scope and contract value. Providers offering integrated template production, circRNA drug substance, LNP formulation, and quality studies will be better positioned to secure long-term projects.
The main barriers are the lack of harmonized quality and regulatory standards and differences in how suppliers measure circularization efficiency, purity, integrity, and expression activity. A high apparent circularization rate does not necessarily indicate high functional purity, because mis-ligated products, uncircularized precursors, double-stranded RNA, and truncated transcripts may affect expression and immune responses. Long-sequence circularization efficiency, purification recovery, and batch consistency remain technical challenges. Clinical-grade production also involves significant costs related to high-grade raw materials, quality validation, facility maintenance, and regulatory documentation. Because the number of clinical-stage exogenous circRNA programs remains limited, GMP capacity utilization and order continuity also constrain the stability of supplier profitability.
This report is a detailed and comprehensive analysis for global Exogenous Circular RNA Synthesis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Exogenous Circular RNA Synthesis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Exogenous Circular RNA Synthesis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Exogenous Circular RNA Synthesis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Exogenous Circular RNA Synthesis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Exogenous Circular RNA Synthesis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Exogenous Circular RNA Synthesis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Exogenous Circular RNA Synthesis Service, with revenue, gross margin, and global market share of Exogenous Circular RNA Synthesis Service from 2021 to 2026.
Chapter 3, the Exogenous Circular RNA Synthesis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Exogenous Circular RNA Synthesis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Exogenous Circular RNA Synthesis Service.
Chapter 13, to describe Exogenous Circular RNA Synthesis Service research findings and conclusion.
Exogenous circular RNA synthesis services refer to specialized technical services that produce artificial circular RNA outside living cells based on customer-provided or jointly optimized sequences. The workflow typically includes DNA template construction, in vitro transcription, precursor RNA circularization, purification, analytical testing, and optional lipid nanoparticle formulation and clinical-grade manufacturing. The delivered RNA has already formed a covalently closed circular structure before being introduced into cells, tissues, or living organisms. Major circularization routes include PIE self-splicing, modified scarless PIE methods, and T4 RNA ligase-mediated enzymatic ligation. Deliverables include research-grade circRNA samples, preclinical drug substance, formulated samples, process-development packages, and GMP-compliant clinical batches. Upstream inputs mainly include nucleotide triphosphates, modified nucleosides, DNA and plasmid templates, RNA polymerases, RNA ligases, ribozyme elements, nucleases, buffers, chromatography media, ultrafiltration consumables, single-use bioprocessing materials, analytical reagents, and lipid materials. Downstream customers primarily include RNA drug developers, vaccine companies, gene and cell therapy companies, pharmaceutical companies, universities, research institutes, and hospital research centers. Pricing is generally determined by sequence length, delivery scale, circularization method, purity grade, analytical requirements, formulation needs, and quality-system requirements. Research-grade projects are usually priced by sequence and quantity, while clinical and industrial projects are priced through process-development and batch-manufacturing contracts. The industry's overall gross margin in 2025 is estimated at approximately 40%?60%.
The exogenous circular RNA synthesis services market is still dominated by research-grade and preclinical projects, although customer demand is expanding from basic circRNA sample preparation to sequence optimization, circularization screening, impurity removal, analytical method development, and delivery formulation. Early suppliers mainly delivered microgram- to milligram-scale research samples, while several integrated service providers have developed larger-scale production, LNP formulation, and clinical-grade quality systems. Global supply is concentrated mainly in China and the United States. Chinese providers have developed broad capabilities in circularization processes, research services, and integrated CRDMO support, while U.S.-based providers generally benefit from international customer coverage, standardized service models, and established nucleic acid development infrastructure. The market remains characterized by a limited supplier base, highly customized projects, and revenues concentrated in the development stage.
Future competition will shift from basic circularization capability toward high purity, scarless products, long-sequence compatibility, low immunogenicity, and reproducible scale-up. Conventional PIE methods have a relatively established application base but may face challenges involving junction scars, sequence restrictions, and by-product control. Modified scarless PIE and ligase-based approaches offer greater sequence flexibility but impose additional requirements on terminal structure, splint design, enzyme cost, and downstream purification. As customer programs enter clinical development, residual linear RNA, double-stranded RNA, truncated transcripts, free intron fragments, and residual DNA will become increasingly important quality attributes. Suppliers with proprietary analytical methods and biological potency testing capabilities will gain a stronger competitive position.
Market growth is being driven by expanding development activity in circular RNA therapeutics, therapeutic vaccines, protein-expression therapies, in vivo cell therapies, and gene-editing research. Compared with building internal in vitro transcription and circularization platforms, outsourcing gives developers access to validated templates, circularization elements, purification processes, and analytical systems, reducing development risk and shortening timelines to animal studies and regulatory submissions. As programs move from discovery to preclinical and clinical stages, additional testing for circularization efficiency, purity, integrity, residual DNA, double-stranded RNA, endotoxin, sterility, and potency expands the service scope and contract value. Providers offering integrated template production, circRNA drug substance, LNP formulation, and quality studies will be better positioned to secure long-term projects.
The main barriers are the lack of harmonized quality and regulatory standards and differences in how suppliers measure circularization efficiency, purity, integrity, and expression activity. A high apparent circularization rate does not necessarily indicate high functional purity, because mis-ligated products, uncircularized precursors, double-stranded RNA, and truncated transcripts may affect expression and immune responses. Long-sequence circularization efficiency, purification recovery, and batch consistency remain technical challenges. Clinical-grade production also involves significant costs related to high-grade raw materials, quality validation, facility maintenance, and regulatory documentation. Because the number of clinical-stage exogenous circRNA programs remains limited, GMP capacity utilization and order continuity also constrain the stability of supplier profitability.
This report is a detailed and comprehensive analysis for global Exogenous Circular RNA Synthesis Service market. Both quantitative and qualitative analyses are presented by company, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Exogenous Circular RNA Synthesis Service market size and forecasts, in consumption value ($ Million), 2021-2032
Global Exogenous Circular RNA Synthesis Service market size and forecasts by region and country, in consumption value ($ Million), 2021-2032
Global Exogenous Circular RNA Synthesis Service market size and forecasts, by Type and by Application, in consumption value ($ Million), 2021-2032
Global Exogenous Circular RNA Synthesis Service market shares of main players, in revenue ($ Million), 2021-2026
The Primary Objectives in This Report Are:
- To determine the size of the total market opportunity of global and key countries
- To assess the growth potential for Exogenous Circular RNA Synthesis Service
- To forecast future growth in each product and end-use market
- To assess competitive factors affecting the marketplace
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market segmentation
Exogenous Circular RNA Synthesis Service market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for Consumption Value by Type and by Application. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
- Custom Synthesis
- Process Development
- Analytical and QC Services
- Other
- PIE Circularization
- Enzymatic Ligation
- Other
- Naked circRNA
- circRNA-LNP
- Other
- Pharmaceutical and Biotechnology Companies
- CRO and CDMO Companies
- Other
- GenScript Biotech Corporation
- VectorBuilder
- Guangzhou Geneseed Biotech
- uBriGene Biosciences
- Yaohai Bio-Pharma
- Creative Biogene
- Creative Biolabs
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia, Italy and Rest of Europe)
Asia-Pacific (China, Japan, South Korea, India, Southeast Asia and Rest of Asia-Pacific)
South America (Brazil, Rest of South America)
Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of Middle East & Africa)
The content of the study subjects, includes a total of 13 chapters:
Chapter 1, to describe Exogenous Circular RNA Synthesis Service product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top players of Exogenous Circular RNA Synthesis Service, with revenue, gross margin, and global market share of Exogenous Circular RNA Synthesis Service from 2021 to 2026.
Chapter 3, the Exogenous Circular RNA Synthesis Service competitive situation, revenue, and global market share of top players are analyzed emphatically by landscape contrast.
Chapter 4 and 5, to segment the market size by Type and by Application, with consumption value and growth rate by Type, by Application, from 2021 to 2032.
Chapter 6, 7, 8, 9, and 10, to break the market size data at the country level, with revenue and market share for key countries in the world, from 2021 to 2026.and Exogenous Circular RNA Synthesis Service market forecast, by regions, by Type and by Application, with consumption value, from 2027 to 2032.
Chapter 11, market dynamics, drivers, restraints, trends, Porters Five Forces analysis.
Chapter 12, the key raw materials and key suppliers, and industry chain of Exogenous Circular RNA Synthesis Service.
Chapter 13, to describe Exogenous Circular RNA Synthesis Service research findings and conclusion.
1 MARKET OVERVIEW
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Exogenous Circular RNA Synthesis Service by Type
1.3.1 Overview: Global Exogenous Circular RNA Synthesis Service Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type in 2025
1.3.3 Custom Synthesis
1.3.4 Process Development
1.3.5 Analytical and QC Services
1.3.6 Other
1.4 Classification of Exogenous Circular RNA Synthesis Service by Circularization Method
1.4.1 Overview: Global Exogenous Circular RNA Synthesis Service Market Size by Circularization Method: 2021 Versus 2025 Versus 2032
1.4.2 Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Circularization Method in 2025
1.4.3 PIE Circularization
1.4.4 Enzymatic Ligation
1.4.5 Other
1.5 Classification of Exogenous Circular RNA Synthesis Service by Product Format
1.5.1 Overview: Global Exogenous Circular RNA Synthesis Service Market Size by Product Format: 2021 Versus 2025 Versus 2032
1.5.2 Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Product Format in 2025
1.5.3 Naked circRNA
1.5.4 circRNA-LNP
1.5.5 Other
1.6 Global Exogenous Circular RNA Synthesis Service Market by Application
1.6.1 Overview: Global Exogenous Circular RNA Synthesis Service Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical and Biotechnology Companies
1.6.3 CRO and CDMO Companies
1.6.4 Other
1.7 Global Exogenous Circular RNA Synthesis Service Market Size & Forecast
1.8 Global Exogenous Circular RNA Synthesis Service Market Size and Forecast by Region
1.8.1 Global Exogenous Circular RNA Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Exogenous Circular RNA Synthesis Service Market Size by Region, (2021-2032)
1.8.3 North America Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.4 Europe Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.6 South America Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 GenScript Biotech Corporation
2.1.1 GenScript Biotech Corporation Details
2.1.2 GenScript Biotech Corporation Major Business
2.1.3 GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Product and Solutions
2.1.4 GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 GenScript Biotech Corporation Recent Developments and Future Plans
2.2 VectorBuilder
2.2.1 VectorBuilder Details
2.2.2 VectorBuilder Major Business
2.2.3 VectorBuilder Exogenous Circular RNA Synthesis Service Product and Solutions
2.2.4 VectorBuilder Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 VectorBuilder Recent Developments and Future Plans
2.3 Guangzhou Geneseed Biotech
2.3.1 Guangzhou Geneseed Biotech Details
2.3.2 Guangzhou Geneseed Biotech Major Business
2.3.3 Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Product and Solutions
2.3.4 Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Guangzhou Geneseed Biotech Recent Developments and Future Plans
2.4 uBriGene Biosciences
2.4.1 uBriGene Biosciences Details
2.4.2 uBriGene Biosciences Major Business
2.4.3 uBriGene Biosciences Exogenous Circular RNA Synthesis Service Product and Solutions
2.4.4 uBriGene Biosciences Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 uBriGene Biosciences Recent Developments and Future Plans
2.5 Yaohai Bio-Pharma
2.5.1 Yaohai Bio-Pharma Details
2.5.2 Yaohai Bio-Pharma Major Business
2.5.3 Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Product and Solutions
2.5.4 Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yaohai Bio-Pharma Recent Developments and Future Plans
2.6 Creative Biogene
2.6.1 Creative Biogene Details
2.6.2 Creative Biogene Major Business
2.6.3 Creative Biogene Exogenous Circular RNA Synthesis Service Product and Solutions
2.6.4 Creative Biogene Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Creative Biogene Recent Developments and Future Plans
2.7 Creative Biolabs
2.7.1 Creative Biolabs Details
2.7.2 Creative Biolabs Major Business
2.7.3 Creative Biolabs Exogenous Circular RNA Synthesis Service Product and Solutions
2.7.4 Creative Biolabs Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Creative Biolabs Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Exogenous Circular RNA Synthesis Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Exogenous Circular RNA Synthesis Service by Company Revenue
3.2.2 Top 3 Exogenous Circular RNA Synthesis Service Players Market Share in 2025
3.2.3 Top 6 Exogenous Circular RNA Synthesis Service Players Market Share in 2025
3.3 Exogenous Circular RNA Synthesis Service Market: Overall Company Footprint Analysis
3.3.1 Exogenous Circular RNA Synthesis Service Market: Region Footprint
3.3.2 Exogenous Circular RNA Synthesis Service Market: Company Product Type Footprint
3.3.3 Exogenous Circular RNA Synthesis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Exogenous Circular RNA Synthesis Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Exogenous Circular RNA Synthesis Service Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Exogenous Circular RNA Synthesis Service Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
6.2 North America Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2032)
6.3 North America Exogenous Circular RNA Synthesis Service Market Size by Country
6.3.1 North America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
6.3.2 United States Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
6.3.3 Canada Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
6.3.4 Mexico Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
7.2 Europe Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
7.3 Europe Exogenous Circular RNA Synthesis Service Market Size by Country
7.3.1 Europe Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
7.3.2 Germany Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.3 France Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.5 Russia Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.6 Italy Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size by Region
8.3.1 Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Region (2021-2032)
8.3.2 China Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.3 Japan Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.4 South Korea Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.5 India Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.7 Australia Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
9.2 South America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
9.3 South America Exogenous Circular RNA Synthesis Service Market Size by Country
9.3.1 South America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
9.3.2 Brazil Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
9.3.3 Argentina Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Country
10.3.1 Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
10.3.2 Turkey Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10.3.4 UAE Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Exogenous Circular RNA Synthesis Service Market Drivers
11.2 Exogenous Circular RNA Synthesis Service Market Restraints
11.3 Exogenous Circular RNA Synthesis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Exogenous Circular RNA Synthesis Service Industry Chain
12.2 Exogenous Circular RNA Synthesis Service Upstream Analysis
12.3 Exogenous Circular RNA Synthesis Service Midstream Analysis
12.4 Exogenous Circular RNA Synthesis Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
1.1 Product Overview and Scope
1.2 Market Estimation Caveats and Base Year
1.3 Classification of Exogenous Circular RNA Synthesis Service by Type
1.3.1 Overview: Global Exogenous Circular RNA Synthesis Service Market Size by Type: 2021 Versus 2025 Versus 2032
1.3.2 Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type in 2025
1.3.3 Custom Synthesis
1.3.4 Process Development
1.3.5 Analytical and QC Services
1.3.6 Other
1.4 Classification of Exogenous Circular RNA Synthesis Service by Circularization Method
1.4.1 Overview: Global Exogenous Circular RNA Synthesis Service Market Size by Circularization Method: 2021 Versus 2025 Versus 2032
1.4.2 Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Circularization Method in 2025
1.4.3 PIE Circularization
1.4.4 Enzymatic Ligation
1.4.5 Other
1.5 Classification of Exogenous Circular RNA Synthesis Service by Product Format
1.5.1 Overview: Global Exogenous Circular RNA Synthesis Service Market Size by Product Format: 2021 Versus 2025 Versus 2032
1.5.2 Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Product Format in 2025
1.5.3 Naked circRNA
1.5.4 circRNA-LNP
1.5.5 Other
1.6 Global Exogenous Circular RNA Synthesis Service Market by Application
1.6.1 Overview: Global Exogenous Circular RNA Synthesis Service Market Size by Application: 2021 Versus 2025 Versus 2032
1.6.2 Pharmaceutical and Biotechnology Companies
1.6.3 CRO and CDMO Companies
1.6.4 Other
1.7 Global Exogenous Circular RNA Synthesis Service Market Size & Forecast
1.8 Global Exogenous Circular RNA Synthesis Service Market Size and Forecast by Region
1.8.1 Global Exogenous Circular RNA Synthesis Service Market Size by Region: 2021 VS 2025 VS 2032
1.8.2 Global Exogenous Circular RNA Synthesis Service Market Size by Region, (2021-2032)
1.8.3 North America Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.4 Europe Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.5 Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.6 South America Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
1.8.7 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size and Prospect (2021-2032)
2 COMPANY PROFILES
2.1 GenScript Biotech Corporation
2.1.1 GenScript Biotech Corporation Details
2.1.2 GenScript Biotech Corporation Major Business
2.1.3 GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Product and Solutions
2.1.4 GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.1.5 GenScript Biotech Corporation Recent Developments and Future Plans
2.2 VectorBuilder
2.2.1 VectorBuilder Details
2.2.2 VectorBuilder Major Business
2.2.3 VectorBuilder Exogenous Circular RNA Synthesis Service Product and Solutions
2.2.4 VectorBuilder Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.2.5 VectorBuilder Recent Developments and Future Plans
2.3 Guangzhou Geneseed Biotech
2.3.1 Guangzhou Geneseed Biotech Details
2.3.2 Guangzhou Geneseed Biotech Major Business
2.3.3 Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Product and Solutions
2.3.4 Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.3.5 Guangzhou Geneseed Biotech Recent Developments and Future Plans
2.4 uBriGene Biosciences
2.4.1 uBriGene Biosciences Details
2.4.2 uBriGene Biosciences Major Business
2.4.3 uBriGene Biosciences Exogenous Circular RNA Synthesis Service Product and Solutions
2.4.4 uBriGene Biosciences Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.4.5 uBriGene Biosciences Recent Developments and Future Plans
2.5 Yaohai Bio-Pharma
2.5.1 Yaohai Bio-Pharma Details
2.5.2 Yaohai Bio-Pharma Major Business
2.5.3 Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Product and Solutions
2.5.4 Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.5.5 Yaohai Bio-Pharma Recent Developments and Future Plans
2.6 Creative Biogene
2.6.1 Creative Biogene Details
2.6.2 Creative Biogene Major Business
2.6.3 Creative Biogene Exogenous Circular RNA Synthesis Service Product and Solutions
2.6.4 Creative Biogene Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.6.5 Creative Biogene Recent Developments and Future Plans
2.7 Creative Biolabs
2.7.1 Creative Biolabs Details
2.7.2 Creative Biolabs Major Business
2.7.3 Creative Biolabs Exogenous Circular RNA Synthesis Service Product and Solutions
2.7.4 Creative Biolabs Exogenous Circular RNA Synthesis Service Revenue, Gross Margin and Market Share (2021-2026)
2.7.5 Creative Biolabs Recent Developments and Future Plans
3 MARKET COMPETITION, BY PLAYERS
3.1 Global Exogenous Circular RNA Synthesis Service Revenue and Share by Players (2021-2026)
3.2 Market Share Analysis (2025)
3.2.1 Market Share of Exogenous Circular RNA Synthesis Service by Company Revenue
3.2.2 Top 3 Exogenous Circular RNA Synthesis Service Players Market Share in 2025
3.2.3 Top 6 Exogenous Circular RNA Synthesis Service Players Market Share in 2025
3.3 Exogenous Circular RNA Synthesis Service Market: Overall Company Footprint Analysis
3.3.1 Exogenous Circular RNA Synthesis Service Market: Region Footprint
3.3.2 Exogenous Circular RNA Synthesis Service Market: Company Product Type Footprint
3.3.3 Exogenous Circular RNA Synthesis Service Market: Company Product Application Footprint
3.4 New Market Entrants and Barriers to Market Entry
3.5 Mergers, Acquisition, Agreements, and Collaborations
4 MARKET SIZE SEGMENT BY TYPE
4.1 Global Exogenous Circular RNA Synthesis Service Consumption Value and Market Share by Type (2021-2026)
4.2 Global Exogenous Circular RNA Synthesis Service Market Forecast by Type (2027-2032)
5 MARKET SIZE SEGMENT BY APPLICATION
5.1 Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2026)
5.2 Global Exogenous Circular RNA Synthesis Service Market Forecast by Application (2027-2032)
6 NORTH AMERICA
6.1 North America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
6.2 North America Exogenous Circular RNA Synthesis Service Market Size by Application (2021-2032)
6.3 North America Exogenous Circular RNA Synthesis Service Market Size by Country
6.3.1 North America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
6.3.2 United States Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
6.3.3 Canada Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
6.3.4 Mexico Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7 EUROPE
7.1 Europe Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
7.2 Europe Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
7.3 Europe Exogenous Circular RNA Synthesis Service Market Size by Country
7.3.1 Europe Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
7.3.2 Germany Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.3 France Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.4 United Kingdom Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.5 Russia Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
7.3.6 Italy Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8 ASIA-PACIFIC
8.1 Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
8.2 Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
8.3 Asia-Pacific Exogenous Circular RNA Synthesis Service Market Size by Region
8.3.1 Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Region (2021-2032)
8.3.2 China Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.3 Japan Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.4 South Korea Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.5 India Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.6 Southeast Asia Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
8.3.7 Australia Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
9 SOUTH AMERICA
9.1 South America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
9.2 South America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
9.3 South America Exogenous Circular RNA Synthesis Service Market Size by Country
9.3.1 South America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
9.3.2 Brazil Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
9.3.3 Argentina Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10 MIDDLE EAST & AFRICA
10.1 Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2032)
10.2 Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2032)
10.3 Middle East & Africa Exogenous Circular RNA Synthesis Service Market Size by Country
10.3.1 Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2032)
10.3.2 Turkey Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10.3.3 Saudi Arabia Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
10.3.4 UAE Exogenous Circular RNA Synthesis Service Market Size and Forecast (2021-2032)
11 MARKET DYNAMICS
11.1 Exogenous Circular RNA Synthesis Service Market Drivers
11.2 Exogenous Circular RNA Synthesis Service Market Restraints
11.3 Exogenous Circular RNA Synthesis Service Trends Analysis
11.4 Porters Five Forces Analysis
11.4.1 Threat of New Entrants
11.4.2 Bargaining Power of Suppliers
11.4.3 Bargaining Power of Buyers
11.4.4 Threat of Substitutes
11.4.5 Competitive Rivalry
12 INDUSTRY CHAIN ANALYSIS
12.1 Exogenous Circular RNA Synthesis Service Industry Chain
12.2 Exogenous Circular RNA Synthesis Service Upstream Analysis
12.3 Exogenous Circular RNA Synthesis Service Midstream Analysis
12.4 Exogenous Circular RNA Synthesis Service Downstream Analysis
13 RESEARCH FINDINGS AND CONCLUSION
14 APPENDIX
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
LIST OF TABLES
Table 1. Global Exogenous Circular RNA Synthesis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Exogenous Circular RNA Synthesis Service Consumption Value by Circularization Method, (USD Million), 2021 & 2025 & 2032
Table 3. Global Exogenous Circular RNA Synthesis Service Consumption Value by Product Format, (USD Million), 2021 & 2025 & 2032
Table 4. Global Exogenous Circular RNA Synthesis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Exogenous Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Exogenous Circular RNA Synthesis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. GenScript Biotech Corporation Company Information, Head Office, and Major Competitors
Table 8. GenScript Biotech Corporation Major Business
Table 9. GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Product and Solutions
Table 10. GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. GenScript Biotech Corporation Recent Developments and Future Plans
Table 12. VectorBuilder Company Information, Head Office, and Major Competitors
Table 13. VectorBuilder Major Business
Table 14. VectorBuilder Exogenous Circular RNA Synthesis Service Product and Solutions
Table 15. VectorBuilder Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. VectorBuilder Recent Developments and Future Plans
Table 17. Guangzhou Geneseed Biotech Company Information, Head Office, and Major Competitors
Table 18. Guangzhou Geneseed Biotech Major Business
Table 19. Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Product and Solutions
Table 20. Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. uBriGene Biosciences Company Information, Head Office, and Major Competitors
Table 22. uBriGene Biosciences Major Business
Table 23. uBriGene Biosciences Exogenous Circular RNA Synthesis Service Product and Solutions
Table 24. uBriGene Biosciences Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. uBriGene Biosciences Recent Developments and Future Plans
Table 26. Yaohai Bio-Pharma Company Information, Head Office, and Major Competitors
Table 27. Yaohai Bio-Pharma Major Business
Table 28. Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Product and Solutions
Table 29. Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Yaohai Bio-Pharma Recent Developments and Future Plans
Table 31. Creative Biogene Company Information, Head Office, and Major Competitors
Table 32. Creative Biogene Major Business
Table 33. Creative Biogene Exogenous Circular RNA Synthesis Service Product and Solutions
Table 34. Creative Biogene Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Creative Biogene Recent Developments and Future Plans
Table 36. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 37. Creative Biolabs Major Business
Table 38. Creative Biolabs Exogenous Circular RNA Synthesis Service Product and Solutions
Table 39. Creative Biolabs Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Creative Biolabs Recent Developments and Future Plans
Table 41. Global Exogenous Circular RNA Synthesis Service Revenue (USD Million) by Players (2021-2026)
Table 42. Global Exogenous Circular RNA Synthesis Service Revenue Share by Players (2021-2026)
Table 43. Breakdown of Exogenous Circular RNA Synthesis Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 44. Market Position of Players in Exogenous Circular RNA Synthesis Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 45. Head Office of Key Exogenous Circular RNA Synthesis Service Players
Table 46. Exogenous Circular RNA Synthesis Service Market: Company Product Type Footprint
Table 47. Exogenous Circular RNA Synthesis Service Market: Company Product Application Footprint
Table 48. Exogenous Circular RNA Synthesis Service New Market Entrants and Barriers to Market Entry
Table 49. Exogenous Circular RNA Synthesis Service Mergers, Acquisition, Agreements, and Collaborations
Table 50. Global Exogenous Circular RNA Synthesis Service Consumption Value (USD Million) by Type (2021-2026)
Table 51. Global Exogenous Circular RNA Synthesis Service Consumption Value Share by Type (2021-2026)
Table 52. Global Exogenous Circular RNA Synthesis Service Consumption Value Forecast by Type (2027-2032)
Table 53. Global Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026)
Table 54. Global Exogenous Circular RNA Synthesis Service Consumption Value Forecast by Application (2027-2032)
Table 55. North America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 56. North America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 57. North America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 58. North America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 59. North America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 60. North America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 61. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 62. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 63. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 64. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 65. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 66. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 67. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 68. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 69. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 70. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 71. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 73. South America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 74. South America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 75. South America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 76. South America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 77. South America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 78. South America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 80. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 81. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 82. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 83. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 85. Global Key Players of Exogenous Circular RNA Synthesis Service Upstream (Raw Materials)
Table 86. Global Exogenous Circular RNA Synthesis Service Typical Customers
Table 1. Global Exogenous Circular RNA Synthesis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Table 2. Global Exogenous Circular RNA Synthesis Service Consumption Value by Circularization Method, (USD Million), 2021 & 2025 & 2032
Table 3. Global Exogenous Circular RNA Synthesis Service Consumption Value by Product Format, (USD Million), 2021 & 2025 & 2032
Table 4. Global Exogenous Circular RNA Synthesis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Table 5. Global Exogenous Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 6. Global Exogenous Circular RNA Synthesis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 7. GenScript Biotech Corporation Company Information, Head Office, and Major Competitors
Table 8. GenScript Biotech Corporation Major Business
Table 9. GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Product and Solutions
Table 10. GenScript Biotech Corporation Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 11. GenScript Biotech Corporation Recent Developments and Future Plans
Table 12. VectorBuilder Company Information, Head Office, and Major Competitors
Table 13. VectorBuilder Major Business
Table 14. VectorBuilder Exogenous Circular RNA Synthesis Service Product and Solutions
Table 15. VectorBuilder Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 16. VectorBuilder Recent Developments and Future Plans
Table 17. Guangzhou Geneseed Biotech Company Information, Head Office, and Major Competitors
Table 18. Guangzhou Geneseed Biotech Major Business
Table 19. Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Product and Solutions
Table 20. Guangzhou Geneseed Biotech Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 21. uBriGene Biosciences Company Information, Head Office, and Major Competitors
Table 22. uBriGene Biosciences Major Business
Table 23. uBriGene Biosciences Exogenous Circular RNA Synthesis Service Product and Solutions
Table 24. uBriGene Biosciences Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 25. uBriGene Biosciences Recent Developments and Future Plans
Table 26. Yaohai Bio-Pharma Company Information, Head Office, and Major Competitors
Table 27. Yaohai Bio-Pharma Major Business
Table 28. Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Product and Solutions
Table 29. Yaohai Bio-Pharma Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 30. Yaohai Bio-Pharma Recent Developments and Future Plans
Table 31. Creative Biogene Company Information, Head Office, and Major Competitors
Table 32. Creative Biogene Major Business
Table 33. Creative Biogene Exogenous Circular RNA Synthesis Service Product and Solutions
Table 34. Creative Biogene Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 35. Creative Biogene Recent Developments and Future Plans
Table 36. Creative Biolabs Company Information, Head Office, and Major Competitors
Table 37. Creative Biolabs Major Business
Table 38. Creative Biolabs Exogenous Circular RNA Synthesis Service Product and Solutions
Table 39. Creative Biolabs Exogenous Circular RNA Synthesis Service Revenue (USD Million), Gross Margin and Market Share (2021-2026)
Table 40. Creative Biolabs Recent Developments and Future Plans
Table 41. Global Exogenous Circular RNA Synthesis Service Revenue (USD Million) by Players (2021-2026)
Table 42. Global Exogenous Circular RNA Synthesis Service Revenue Share by Players (2021-2026)
Table 43. Breakdown of Exogenous Circular RNA Synthesis Service by Company Type (Tier 1, Tier 2, and Tier 3)
Table 44. Market Position of Players in Exogenous Circular RNA Synthesis Service, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2025
Table 45. Head Office of Key Exogenous Circular RNA Synthesis Service Players
Table 46. Exogenous Circular RNA Synthesis Service Market: Company Product Type Footprint
Table 47. Exogenous Circular RNA Synthesis Service Market: Company Product Application Footprint
Table 48. Exogenous Circular RNA Synthesis Service New Market Entrants and Barriers to Market Entry
Table 49. Exogenous Circular RNA Synthesis Service Mergers, Acquisition, Agreements, and Collaborations
Table 50. Global Exogenous Circular RNA Synthesis Service Consumption Value (USD Million) by Type (2021-2026)
Table 51. Global Exogenous Circular RNA Synthesis Service Consumption Value Share by Type (2021-2026)
Table 52. Global Exogenous Circular RNA Synthesis Service Consumption Value Forecast by Type (2027-2032)
Table 53. Global Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026)
Table 54. Global Exogenous Circular RNA Synthesis Service Consumption Value Forecast by Application (2027-2032)
Table 55. North America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 56. North America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 57. North America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 58. North America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 59. North America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 60. North America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 61. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 62. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 63. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 64. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 65. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 66. Europe Exogenous Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 67. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 68. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 69. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 70. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 71. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Region (2021-2026) & (USD Million)
Table 72. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value by Region (2027-2032) & (USD Million)
Table 73. South America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 74. South America Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 75. South America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 76. South America Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 77. South America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 78. South America Exogenous Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 79. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Type (2021-2026) & (USD Million)
Table 80. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Type (2027-2032) & (USD Million)
Table 81. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Application (2021-2026) & (USD Million)
Table 82. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Application (2027-2032) & (USD Million)
Table 83. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Country (2021-2026) & (USD Million)
Table 84. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value by Country (2027-2032) & (USD Million)
Table 85. Global Key Players of Exogenous Circular RNA Synthesis Service Upstream (Raw Materials)
Table 86. Global Exogenous Circular RNA Synthesis Service Typical Customers
LIST OF FIGURES
Figure 1. Exogenous Circular RNA Synthesis Service Picture
Figure 2. Global Exogenous Circular RNA Synthesis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type in 2025
Figure 4. Custom Synthesis
Figure 5. Process Development
Figure 6. Analytical and QC Services
Figure 7. Other
Figure 8. Global Exogenous Circular RNA Synthesis Service Consumption Value by Circularization Method, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Circularization Method in 2025
Figure 10. PIE Circularization
Figure 11. Enzymatic Ligation
Figure 12. Other
Figure 13. Global Exogenous Circular RNA Synthesis Service Consumption Value by Product Format, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Product Format in 2025
Figure 15. Naked circRNA
Figure 16. circRNA-LNP
Figure 17. Other
Figure 18. Global Exogenous Circular RNA Synthesis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application in 2025
Figure 20. Pharmaceutical and Biotechnology Companies Picture
Figure 21. CRO and CDMO Companies Picture
Figure 22. Other Picture
Figure 23. Global Exogenous Circular RNA Synthesis Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Exogenous Circular RNA Synthesis Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Exogenous Circular RNA Synthesis Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Region in 2025
Figure 28. North America Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Exogenous Circular RNA Synthesis Service Revenue Share by Players in 2025
Figure 35. Exogenous Circular RNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Exogenous Circular RNA Synthesis Service by Player Revenue in 2025
Figure 37. Top 3 Exogenous Circular RNA Synthesis Service Players Market Share in 2025
Figure 38. Top 6 Exogenous Circular RNA Synthesis Service Players Market Share in 2025
Figure 39. Global Exogenous Circular RNA Synthesis Service Consumption Value Share by Type (2021-2026)
Figure 40. Global Exogenous Circular RNA Synthesis Service Market Share Forecast by Type (2027-2032)
Figure 41. Global Exogenous Circular RNA Synthesis Service Consumption Value Share by Application (2021-2026)
Figure 42. Global Exogenous Circular RNA Synthesis Service Market Share Forecast by Application (2027-2032)
Figure 43. North America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 53. France Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 60. China Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 63. India Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 77. Exogenous Circular RNA Synthesis Service Market Drivers
Figure 78. Exogenous Circular RNA Synthesis Service Market Restraints
Figure 79. Exogenous Circular RNA Synthesis Service Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Exogenous Circular RNA Synthesis Service Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source
Figure 1. Exogenous Circular RNA Synthesis Service Picture
Figure 2. Global Exogenous Circular RNA Synthesis Service Consumption Value by Type, (USD Million), 2021 & 2025 & 2032
Figure 3. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type in 2025
Figure 4. Custom Synthesis
Figure 5. Process Development
Figure 6. Analytical and QC Services
Figure 7. Other
Figure 8. Global Exogenous Circular RNA Synthesis Service Consumption Value by Circularization Method, (USD Million), 2021 & 2025 & 2032
Figure 9. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Circularization Method in 2025
Figure 10. PIE Circularization
Figure 11. Enzymatic Ligation
Figure 12. Other
Figure 13. Global Exogenous Circular RNA Synthesis Service Consumption Value by Product Format, (USD Million), 2021 & 2025 & 2032
Figure 14. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Product Format in 2025
Figure 15. Naked circRNA
Figure 16. circRNA-LNP
Figure 17. Other
Figure 18. Global Exogenous Circular RNA Synthesis Service Consumption Value by Application, (USD Million), 2021 & 2025 & 2032
Figure 19. Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application in 2025
Figure 20. Pharmaceutical and Biotechnology Companies Picture
Figure 21. CRO and CDMO Companies Picture
Figure 22. Other Picture
Figure 23. Global Exogenous Circular RNA Synthesis Service Consumption Value, (USD Million): 2021 & 2025 & 2032
Figure 24. Global Exogenous Circular RNA Synthesis Service Consumption Value and Forecast (2021-2032) & (USD Million)
Figure 25. Global Market Exogenous Circular RNA Synthesis Service Consumption Value (USD Million) Comparison by Region (2021 VS 2025 VS 2032)
Figure 26. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 27. Global Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Region in 2025
Figure 28. North America Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 29. Europe Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 30. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 31. South America Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 32. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 33. Company Three Recent Developments and Future Plans
Figure 34. Global Exogenous Circular RNA Synthesis Service Revenue Share by Players in 2025
Figure 35. Exogenous Circular RNA Synthesis Service Market Share by Company Type (Tier 1, Tier 2, and Tier 3) in 2025
Figure 36. Market Share of Exogenous Circular RNA Synthesis Service by Player Revenue in 2025
Figure 37. Top 3 Exogenous Circular RNA Synthesis Service Players Market Share in 2025
Figure 38. Top 6 Exogenous Circular RNA Synthesis Service Players Market Share in 2025
Figure 39. Global Exogenous Circular RNA Synthesis Service Consumption Value Share by Type (2021-2026)
Figure 40. Global Exogenous Circular RNA Synthesis Service Market Share Forecast by Type (2027-2032)
Figure 41. Global Exogenous Circular RNA Synthesis Service Consumption Value Share by Application (2021-2026)
Figure 42. Global Exogenous Circular RNA Synthesis Service Market Share Forecast by Application (2027-2032)
Figure 43. North America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 44. North America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 45. North America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 46. United States Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 47. Canada Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 48. Mexico Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 49. Europe Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 50. Europe Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 51. Europe Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 52. Germany Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 53. France Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 54. United Kingdom Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 55. Russia Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 56. Italy Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 57. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 58. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 59. Asia-Pacific Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Region (2021-2032)
Figure 60. China Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 61. Japan Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 62. South Korea Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 63. India Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 64. Southeast Asia Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 65. Australia Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 66. South America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 67. South America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 68. South America Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 69. Brazil Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 70. Argentina Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 71. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Type (2021-2032)
Figure 72. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Application (2021-2032)
Figure 73. Middle East & Africa Exogenous Circular RNA Synthesis Service Consumption Value Market Share by Country (2021-2032)
Figure 74. Turkey Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 75. Saudi Arabia Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 76. UAE Exogenous Circular RNA Synthesis Service Consumption Value (2021-2032) & (USD Million)
Figure 77. Exogenous Circular RNA Synthesis Service Market Drivers
Figure 78. Exogenous Circular RNA Synthesis Service Market Restraints
Figure 79. Exogenous Circular RNA Synthesis Service Market Trends
Figure 80. Porters Five Forces Analysis
Figure 81. Exogenous Circular RNA Synthesis Service Industrial Chain
Figure 82. Methodology
Figure 83. Research Process and Data Source
